Norfloxacin-<wbr/>d<sub>5</sub>

Norfloxacin-d5

CAT N°: 28521
Price:

From 83.00 70.55

Norfloxacin-d5 is intended for use as an internal standard for the quantification of norfloxacin (Item No. 25975) by GC- or LC-MS. Norfloxacin is a fluoroquinolone antibiotic that inhibits the growth of Gram-positive and Gram-negative bacteria (MICs = 4 and 1 ?g/ml for S. aureus and P. aeruginosa, respectively).{45096} It also inhibits the growth S. pseudintermedius, S. aureus, E. coli, Pasturella, and S. canis isolates from dogs (mean MIC50s = 0.25, 1, 0.03, 1, and 1 ?g/ml, respectively).{39898} Topical administration of norfloxacin (0.1% v/v) reduces corneal ulcer size in a rabbit model of P. aeruginosa corneal infection. It also prevents encrusted cystitis in bladder and increases survival in a rat model of Corynebacterium group D2 infection when administered at a dose of 80 mg/kg per day.{45097} Formulations containing norfloxacin have been used to treat urinary tract and gynecological infections.

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 1-(ethyl-1,1,2,2,2-d5)-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid
  • Correlated keywords
    • deuterated deuterium Staphylococcus Pseudomonas Escherichia Streptococcus Coryne-bacterium UTI 4803P 4803-P AM715 AM-715
  • Product Overview:
    Norfloxacin-d5 is intended for use as an internal standard for the quantification of norfloxacin (Item No. 25975) by GC- or LC-MS. Norfloxacin is a fluoroquinolone antibiotic that inhibits the growth of Gram-positive and Gram-negative bacteria (MICs = 4 and 1 ?g/ml for S. aureus and P. aeruginosa, respectively).{45096} It also inhibits the growth S. pseudintermedius, S. aureus, E. coli, Pasturella, and S. canis isolates from dogs (mean MIC50s = 0.25, 1, 0.03, 1, and 1 ?g/ml, respectively).{39898} Topical administration of norfloxacin (0.1% v/v) reduces corneal ulcer size in a rabbit model of P. aeruginosa corneal infection. It also prevents encrusted cystitis in bladder and increases survival in a rat model of Corynebacterium group D2 infection when administered at a dose of 80 mg/kg per day.{45097} Formulations containing norfloxacin have been used to treat urinary tract and gynecological infections.

We also advise you